291 results on '"Skeith, Leslie"'
Search Results
2. Thrombosis recurrence and major bleeding in non-anticoagulated thrombotic antiphospholipid syndrome patients: Prospective study from antiphospholipid syndrome alliance for clinical trials and international networking (APS ACTION) clinical database and repository (“Registry”)
3. Overexpression of facilitative glucose transporter-3 and membrane procoagulation in maternal platelets of preeclamptic pregnancy
4. Associations Among Antiphospholipid Antibody Types, Isotypes, and Titers: An AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Study
5. Preeclampsia: Platelet procoagulant membrane dynamics and critical biomarkers
6. Complications thrombotiques graves du syndrome des antiphospholipides et d'un lupus erythemateux dissemine non diagnostique
7. Evaluation of patients' experience and related qualitative outcomes in venous thromboembolism: A scoping review
8. Identification of outcomes in clinical studies of interventions for venous thromboembolism in non‐pregnant adults: A scoping review
9. Severe thrombotic complications secondary to antiphospholipid syndrome and undiagnosed systemic lupus erythematosus
10. Evaluating research collaboration networks among venous thromboembolism researchers before and during the COVID-19 pandemic
11. Antiphospholipid Syndrome
12. Long‐term risk of recurrent venous thromboembolism after a first contraceptive‐related event: Data from REVERSE cohort study
13. Identification of hypercoagulability with thrombelastography in patients with hip fracture receiving thromboprophylaxis
14. A toolkit for the collection of thrombosis-related data elements in COVID-19 clinical studies
15. Anticoagulant interventions in hospitalized patients with COVID‐19: A scoping review of randomized controlled trials and call for international collaboration
16. Effect of oral anticoagulants on hemostatic and thromboembolic complications in hip fracture: A systematic review and meta‐analysis
17. Anticoagulating patients with high-risk acquired thrombophilias
18. Racial and Ethnic Disparities in Eligibility for Postpartum Venous Thromboembolism Prophylaxis in the United States
19. Racial and ethnic disparities in eligibility for postpartum venous thromboembolism prophylaxis in the United States
20. Risk of venous thromboembolism in pregnant women with essential thrombocythemia: a systematic review and meta-analysis
21. Romiplostim drug presence in pregnancy and lactation
22. A meta-analysis of low-molecular-weight heparin to prevent pregnancy loss in women with inherited thrombophilia
23. Heightened Procoagulation after Post-Operative Thromboprophylaxis Completion in Patients with Metastatic Bone Disease from Primary Colorectal Cancer
24. Platelets and neutrophils co-drive procoagulant potential in secondary antiphospholipid syndrome during pregnancy
25. Menstrual Abnormalities and Reproductive Lifespan in Females with CKD
26. Hypercoagulability and Inflammatory Markers in a Case of Congenital Thrombotic Thrombocytopenic Purpura Complicated by Fetal Demise
27. First-in-Human Detection of Romiplostim Drug Levels in Cord Blood, Breastmilk and Blood in a Woman with ITP and Her Newborn Infant
28. Challenges facing early career women in thrombosis and hemostasis—meeting the needs of the next generation
29. Evaluation of patients’ experience and related qualitative outcomes in venous thromboembolism and anticoagulation: A scoping review
30. Chapter 141 - Prevention and Treatment of Venous Thromboembolism in Pregnancy
31. Recurrence after stopping anticoagulants in women with combined oral contraceptive‐associated venous thromboembolism: A systematic review and meta‐analysis
32. A Meta-analysis of Low-Molecular Weight Heparin to Prevent Pregnancy Loss in Women with Inherited Thrombophilia
33. Preventing Postpartum Venous Thromboembolism in 2022: A Narrative Review
34. Feasibility of establishing a Canadian Obstetric Survey System (CanOSS) for severe maternal morbidity: a study protocol
35. Barriers to Implementing Internist Recommendations for Perioperative Anticoagulation Management by Surgical Teams
36. Prevention and management of venous thromboembolism in pregnancy: cutting through the practice variation
37. Risk of Recurrence after Stopping Anticoagulants in Women with Combined Oral Contraceptive-Associated Venous Thromboembolism: A Systematic Review and Meta-Analysis
38. Antiphospholipid Antibody Profiles and Thrombotic Outcomes in the Starlet Cohort of Patients with Systemic Lupus Erythematosus
39. Activated Platelets Harbor SARS-CoV-2 during Severe COVID-19
40. Impact of the COVID‐19 pandemic on education and clinical training
41. Oral contraceptives and hormone replacement therapy: How strong a risk factor for venous thromboembolism?
42. The equipoise of perioperative anticoagulation management: a Canadian cross-sectional survey
43. Effect of oral anticoagulant use on surgical delay and mortality in hip fracture
44. Early discharge after acute pulmonary embolism: keep quality of life on the radar
45. “Part of the Ritual”: Exploring Patient and Physician Decision Making Regarding Anticoagulation Use in Obstetric Antiphospholipid Syndrome
46. Development and implementation of common data elements for venous thromboembolism research: on behalf of SSC Subcommittee on official Communication from the SSC of the ISTH
47. Platelet Membrane Procoagulation in Preeclampsia
48. Device Surgery without Interruption of Anticoagulation
49. Contributors
50. The challenges and lessons learned in conducting clinical trials in pregnant women with antiphospholipid syndrome
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.